Search research articles
Contact Us
Filters
Showing results (51-60 of 324) with videos related to
Page
of 33
Sort By:
Breast Cancer Research and Treatment
|
July 27, 2007
Issues and controversies in the treatment of HER2 positive metastatic breast cancer
Surabhi Amar, Alvaro Moreno-Aspitia, Edith A Perez
Clinical Advances in Hematology & Oncology : H&O
|
February 24, 2012
Clinical roundtable monograph. Current treatment options for metastatic breast cancer: what now?
Hope S Rugo, Joyce A O'Shaughnessy, Edith A Perez
Current Oncology Reports
|
December 6, 2001
Adjuvant therapy trials of radiotherapy and systemic treatment for breast cancer
Betty A Mincey, Laura A Vallow, Edith A Perez
The Oncologist
|
September 15, 2006
Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer
José Baselga, Edith A Perez, Tadeusz Pienkowski, et al.
Biomarkers in Medicine
|
January 22, 2015
HER2 testing and its predictive utility in anti-HER2 breast cancer therapy
Pooja P Advani, Jennifer A Crozier, Edith A Perez
Clinical Journal of Oncology Nursing
|
June 10, 2010
Adjuvant trastuzumab for HER2-positive early breast cancer
Frances M Palmieri, Charlyn V Myatt, Edith A Perez
Clinical Advances in Hematology & Oncology : H&O
|
June 2, 2006
Advances in adjuvant therapy for breast cancer
Dennis J Slamon, Edward H Romond, Edith A Perez, et al.
Seminars in Oncology
|
October 19, 2004
Improving patient care through molecular diagnostics
Edith A Perez, Lajos Pusztai, Marc Van de Vijver
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Reply to P.G. Gavin et al
Edith A Perez, E Aubrey Thompson, Karla V Ballman
Clinical Breast Cancer
|
May 26, 2010
Changes to adjuvant systemic therapy in breast cancer: a decade in review
Christina A Saurel, Tejal A Patel, Edith A Perez
Page
of 33
Search research articles
Search
Showing results (51-60 of 324) with videos related to
Sort By:
Page
of 33
Breast Cancer Research and Treatment
|
July 27, 2007
Issues and controversies in the treatment of HER2 positive metastatic breast cancer
Surabhi Amar, Alvaro Moreno-Aspitia, Edith A Perez
Clinical Advances in Hematology & Oncology : H&O
|
February 24, 2012
Clinical roundtable monograph. Current treatment options for metastatic breast cancer: what now?
Hope S Rugo, Joyce A O'Shaughnessy, Edith A Perez
Current Oncology Reports
|
December 6, 2001
Adjuvant therapy trials of radiotherapy and systemic treatment for breast cancer
Betty A Mincey, Laura A Vallow, Edith A Perez
The Oncologist
|
September 15, 2006
Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer
José Baselga, Edith A Perez, Tadeusz Pienkowski, et al.
Biomarkers in Medicine
|
January 22, 2015
HER2 testing and its predictive utility in anti-HER2 breast cancer therapy
Pooja P Advani, Jennifer A Crozier, Edith A Perez
Clinical Journal of Oncology Nursing
|
June 10, 2010
Adjuvant trastuzumab for HER2-positive early breast cancer
Frances M Palmieri, Charlyn V Myatt, Edith A Perez
Clinical Advances in Hematology & Oncology : H&O
|
June 2, 2006
Advances in adjuvant therapy for breast cancer
Dennis J Slamon, Edward H Romond, Edith A Perez, et al.
Seminars in Oncology
|
October 19, 2004
Improving patient care through molecular diagnostics
Edith A Perez, Lajos Pusztai, Marc Van de Vijver
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Reply to P.G. Gavin et al
Edith A Perez, E Aubrey Thompson, Karla V Ballman
Clinical Breast Cancer
|
May 26, 2010
Changes to adjuvant systemic therapy in breast cancer: a decade in review
Christina A Saurel, Tejal A Patel, Edith A Perez
Page
of 33